EQAPOL SARS CoV-2 EQA Option 42
Research Grant
Administered By
Duke Human Vaccine Institute
Awarded By
National Institutes of Health
Start Date
November 12, 2020
End Date
September 29, 2021
Administered By
Duke Human Vaccine Institute
Awarded By
National Institutes of Health
Start Date
November 12, 2020
End Date
September 29, 2021